Discovery of novel covalent stabilizers for p53 Y220C using structure-based drug discovery methods
- 13 February 2025
- journal article
- Published by Springer Nature in Molecular Diversity
- Vol. 29 (6) , 6107-6120
Abstract
The p53 Y220C mutation, a prevalent structural variant in human cancers, compromises DNA binding and tumor suppressor functions by destabilizing the protein structure. Leveraging a combined approach of structure-based virtual screening, molecular dynamics simulations, and in vitro assays, we have identified C8, a racemic compound with an indole core and α, β-unsaturated carbonyl groups, as a covalent stabilizer for p53 Y220C. Protein thermal shift and homogeneous time-resolved fluorescence assays confirmed that C8 and its analogs selectively bind to p53 Y220C and restore its DNA binding ability. Subsequent molecular dynamics simulations and structure-activity relationship analyses showed that both enantiomers of C8 form covalent bonds with Cys124 and Cys220, stabilizing the mutant structure. C8 and its analogs emerge as promising lead candidates for restoring the Y220C mutant's transcriptional function, highlights the potential of this scaffold for further optimization into p53 Y220C-targeted therapeutics.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFC3400504)
- Strategic Priority Research Program of the Chinese Academy of Sciences (XDB0830200, XDB0830203)
- National Natural Science Foundation of China (T2225002, 82204278)
- SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program (E2G805H)
- Large-scale Protein Preparation System at the National Facility for Protein Science in Shanghai (NFPS), Shanghai Advanced Research Institute, Chinese Academy of Science, China
- Shanghai Supercomputer Center
- Shanghai Municipal Science and Technology Major Project
- Postdoctoral Fellowship Program of CPSF (GZC20232846)
- China Postdoctoral Science Foundation (2024M763419)
- the youth innovation promotion association cas (2023296)
This publication has 37 references indexed in Scilit:
- Enantiomeric Separation of Racemic Mixtures Using Chiral-Selective and Organic-Solvent-Resistant Thin-Film Composite MembranesACS Applied Materials & Interfaces, 2022
- Theoretical study of myriocin‐binding mechanism targeting serine palmitoyltransferaseChemical Biology & Drug Design, 2021
- Approaches to mitigate the risk of serious adverse reactions in covalent drug designExpert Opinion on Drug Discovery, 2020
- The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic ApproachesAnnual Review of Biochemistry, 2016
- p53 mutations in cancerNature Cell Biology, 2013
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better BenchmarkingJournal of Medicinal Chemistry, 2012
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in BioassaysJournal of Medicinal Chemistry, 2010
- Awakening guardian angels: drugging the p53 pathwayNature Reviews Cancer, 2009
- Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSAJournal of Computational Chemistry, 2009
- Covalent Modifiers: An Orthogonal Approach to Drug DesignJournal of Medicinal Chemistry, 2009